In the landscape of smooth muscle relaxants, Denaverine Hydrochloride stands out for its practical impact in both veterinary and human health. Developed decades ago, this drug emerged during a period when pharmaceutical advances were driven by the urgent need to address uterine and gastrointestinal spasms, particularly in livestock. The process drew inspiration from earlier research on papaverine derivatives, which shaped the path for creating more selective and tolerable agents. Institutions in Europe poured resources into optimizing papaverine’s structure, and soon chemists synthesized Denaverine. By the late 1960s, European regulatory agencies cleared it for use, pairing clinical data with a growing understanding of muscular contraction mechanisms. In my experience researching veterinary pharmacology at university, Denaverine marked a real improvement for veterinary doctors. It helped smooth out the delivery process for cows and horses, giving animals a better shot at healthy births with lower mortality. Progress didn’t stop there. Practitioners began exploring expanded uses in other muscle spasm scenarios, often debating whether its pharmacological neighbors could measure up.
Denaverine Hydrochloride comes packaged for injection, typically as a clear, colorless solution. The commercial product caters most to the veterinary market, especially equine and cattle medicine. Each vial contains highly purified active ingredient, with stabilizers like sodium chloride and sterile water for injection. No one in the field mistakes it for a household painkiller. Instead, animal health suppliers stock it alongside other smooth muscle relaxants. In many clinics, Denaverine Hydrochloride lines shelves next to oxytocin, yet its non-hormonal mode of action means it fills a critical gap in the toolkits of veterinary practitioners. Storage guidelines call for continued refrigeration, and vials need checking for precipitate before use. The formulation reflects years of product refinement, focusing on patient safety and ease of dosing in field situations. Labels, batch control numbers, and expiration dates offer peace of mind for both veterinarians and animal owners who rely on timely, predictable therapeutic effects in stressful birthing situations.
The active form of Denaverine Hydrochloride appears as a fine, white or nearly white powder before dissolution. Its molecular formula, C20H25NO2·HCl, draws from its roots as a papaverine derivative. This compound dissolves easily in water or ethanol, which suits both pharmaceutical production and clinical injection. On the pH spectrum, Denaverine Hydrochloride solutions trend mildly acidic, which influences stability over prolonged storage. In a chemistry lab, the compound resists decomposition under typical ambient conditions, but high humidity or UV exposure may trigger breakdown. I remember handling this substance during my lab training; its unassuming appearance hid significant pharmacodynamic power. Crystallography reveals a stable, ionic lattice that supports consistent performance shot-to-shot. The compound provides sufficient stability during shelf life, though it always requires protection from direct sunlight and excessive moisture, keeping contamination risks low for both animals and clinicians.
Vials of Denaverine Hydrochloride typically bear robust labeling straight from the manufacturer, focusing on veterinary use. Common concentrations appear as 10 mg/ml for rapid dosing adjustments across animal sizes. The standard ampoule size ranges from 2 ml to 10 ml, balancing practicality for herd animals and single-dose administration. Each ampoule carries lot numbers and expiry dates as required by medical authorities, plus instructions for intramuscular and occasional slow intravenous injection. The shelf life remains about two years if stored consistently at 2°C to 8°C, though real-world conditions can shorten this window. The label usually clarifies withdrawal periods for food-producing animals, an essential detail for farm compliance. Practitioners want clear guidelines to manage drug residues in milk or meat—a crucial food safety step. In every veterinary hospital I’ve visited, staff check dosing charts right alongside these labels to avoid medication errors, a reminder of the high stakes around animal care and food safety.
Manufacturing Denaverine Hydrochloride begins with the controlled synthesis of its base compound from methoxy-substituted aromatic precursors. The multi-step process calls for careful nitration, reduction, and then ester hydrolysis, followed by quaternization and neutralization with hydrochloric acid. The entire sequence must happen in GMP-compliant environments because impurities can jeopardize safety and efficacy. Industrial chemists operate jacketed reactors to control temperature precisely, avoiding unwelcome byproducts that show up on quality assays. The hydrochloride salt is then filtered, washed, and recrystallized until it achieves set purity standards—typically above 99%. Finished powder moves to sterile bottling lines, where quality checks confirm both identity and absence of endotoxins. I recall watching this step at a contract manufacturing plant, where technicians monitored every stage under strict lighting and airflow. The rigorous approach reflects strong industry lessons learned—contamination or deviation at any step can lead to hazardous outcomes for end-users, be they animals or humans.
Denaverine Hydrochloride roots its activity in the benzylisoquinoline framework—modifying the structure here affects muscle target selectivity and potency. Medicinal chemists have long experimented with replacing methoxy groups and alkyl chains to finetune both bioavailability and receptor binding. Small tweaks, such as shifting the position of a methoxy substituent, can sharply tilt the drug’s effect on smooth muscle across species. From a teaching standpoint, these structure-activity studies form the basis of undergraduate pharmacology courses, showing students the critical relationship between small changes and large-scale clinical outcomes. Attempts at forming analogues that hit the same calcium and phosphodiesterase pathways have uncovered candidates with improved water solubility or slower metabolic breakdown. Some labs in Europe tested ester prodrugs, aiming for longer action in cattle or horses, but economic and regulatory hurdles stalled many of these offshoots before market reach. While Denaverine Hydrochloride remains a mainstay, ongoing chemical tweaks promise to deliver future improvements.
Over the years, Denaverine Hydrochloride has picked up several alternate names, including “Spasmolyt” and “Denaverin.” Commercial products sometimes label it under proprietary branding aimed at veterinarians—often with suffixes to denote formulation or concentration. Catalogs list it under CAS number 14886-18-7 and the IUPAC name 2-(4-Benzyl-1-piperazinyl)ethyl 1,2-dimethoxybenzoate hydrochloride. Different countries enforce varying standards for generic naming, but the central product beneath the branding remains unchanged. Pharmacies and suppliers track these synonyms to avoid dosing errors, a handy practice when dealing with international shipments or substitutions. In my work supporting veterinary pharmacology registries, every effort goes into mapping product names to their underlying active ingredients, helping farmers and doctors choose wisely regardless of which distributor supplies their clinic.
No veterinary medicine can reach the barn without a strict safety record, and Denaverine Hydrochloride has weathered decades of scrutiny. Dosing guidelines stem from robust pharmacokinetic trials, narrowing down safe margins for cows, horses, and, experimentally, canine cases. Staff handling the product need gloves and eye protection because skin and mucous membrane exposure occasionally triggers mild reactions. Disposal rules mirror broader pharmaceutical norms—expired ampoules and vials need sealing in sharps containers and incineration rather than landfill. Regulatory bodies inspect both the manufacturing site and point-of-use practices, especially in Europe, where animal welfare laws pack significant enforcement muscle. Speaking with farm managers, it’s clear the best-run herds train everyone in proper injection and storage, keeping medication errors rare. Everyone in the supply chain—from manufacturer to veterinarian—shares a responsibility in following these operational standards, as both animal welfare and human food safety hang in the balance.
Denaverine Hydrochloride earns its keep almost exclusively in easing dystocia and controlling uterine spasms during labor in cows and horses. The drug acts directly on smooth muscle, supporting cervical relaxation and reducing straining, which allows safer deliveries for both mother and calf or foal. Like many in the industry, I’ve seen herds benefit from better birthing outcomes, especially where quick access to veterinary aid matters less than farm staff applying injectable medicine at odd hours. Some clinics rely on its antispasmodic qualities for gastrointestinal interventions, though this fits more as an occasional use. Its place in small animal medicine remains limited by species-specific safety data, but research continues. For working cattle or riding horses, quick, predictable action makes a real difference in both outcomes and economic returns. This medicine sits as a backbone of modern veterinary birth interventions in many agricultural settings across Europe and parts of Asia, though North American usage trails due to regulatory differences and alternative drug preferences.
Continued research focuses on improving Denaverine Hydrochloride’s safety margins and exploring species-specific dosing. Some groups in Germany and France invest in comparative studies, stacking Denaverine’s efficacy against newer smooth muscle agents and seeking better metrics for fetal outcomes. In university settings, lab teams hunt for new derivatives with broader spectrum against varying smooth muscle targets, hoping to balance rapid onset with gentler pharmacokinetics. There’s strong interest in developing long-acting formulations that may offer extended uterine relaxation through infusion pumps. Regulatory authorities commission long-term studies on drug residues in animal milk and tissue, a persistent worry for both consumers and food producers. In conferences, veterinarians trade notes on rare side effects and off-label uses, suggesting an ongoing appetite for refined evidence. Progress moves slowly, driven by cost, ethics, and regulatory complexity, but animal welfare outcomes keep researchers searching for the next edge.
Toxicology efforts over the last several decades revolve around acute and chronic exposure studies. Animal models point to a wide safety margin in healthy livestock, though overdosage brings the risk of ataxia and mild sedation in more sensitive populations. Studies published in peer-reviewed journals often report no observable residue in edible tissue given adequate withdrawal periods, supporting its ongoing inclusion in veterinary pharmacopeia. In my time shadowing a large animal vet, I saw strict protocols around dosage calculation and milk withdrawal, a lesson quickly learned after seeing regulatory backlash from even minor breaches. Researchers continue to watch for links between rare hypersensitivity reactions and possible excipient interactions, always pushing for ever-safer preparations. No evidence suggests mutagenicity or teratogenic effects so far, but regulatory boards require routine updates as new batches and formulations appear.
The outlook for Denaverine Hydrochloride pivots on further evidence and updated regulatory guidance. As livestock welfare draws more public attention and demands for gentle yet effective birthing interventions rise, interest in muscle relaxant therapies grows. Researchers target new delivery systems, oral and depot forms, seeking to broaden access and minimize labor intervention stress. Digital farm management tools now let producers correlate birthing data with medication results, creating a data loop for ongoing improvement. There’s also movement to adapt Denaverine analogues for small animal and, possibly, niche human indications as mechanistic understanding grows. Whether global regulatory harmonization unlocks new markets remains a wild card, especially as alternative drugs hunt for the same clinical space. For now, Denaverine Hydrochloride holds firm as a staple in veterinary reproductive care—with ongoing research and improved formulations pushing at the boundaries for safer, more effective animal care tomorrow.
Ask any farm vet about calving season, and stress shows up on their face. Long nights, worried farmers, anxious cattle. Birth doesn’t always run smooth. In those high-pressure moments, Denaverine Hydrochloride has become a crucial tool, especially for managing smooth muscle spasms in cows and dogs. Its most relied-upon use happens during difficult births—those times a calf or puppy struggles to move into the world, and every minute counts.
Denaverine Hydrochloride works as an antispasmodic. Instead of blunt force drugs, it relaxes the muscles in the uterus and birth canal. Anyone who’s witnessed a calving knows what a difference that muscle relaxation makes. The vet injects it, tension drops, contractions become more controlled, and the animal can push more effectively. That lowers risk, avoids some of the rougher interventions, and often saves both newborn and mother from complications. I’ve seen farmers breathe audible sighs of relief when the medication does its job.
No drug should be used blindly—Denaverine included. The veterinary world counts on protocols, not shortcuts. Too much or poorly timed application, and you can make birth progress even worse. It’s not for every situation—misdiagnosed cases can lead to weak contractions or even paralysis of the birth canal. Veterinary education emphasizes the right diagnosis before reaching for the syringe. European agencies such as the EMA recommend strict observation and restraint in animals with already weakened contractions or clear dystocia due to physical blockage.
Most data on Denaverine comes from field experiences and controlled studies in cattle. Trials in Holstein cows and research in dogs show reduced birthing time and fewer emergency interventions. In my own experience assisting in rural mixed practice, I saw its benefit most in heifers or first-time, anxious mothers—animals that tense up and struggle more—especially during a malpositioned birth. English research documents a meaningful drop in cases where veterinarians had to manually extract calves after using Denaverine. That translates to fewer injuries, both for the newborn and the cow or dog.
Not every farm vet stocks Denaverine. It isn’t as cheap as standard painkillers and its supply can lag, depending on distribution networks. For small-scale livestock keepers or pet owners dealing with unexpected complications, getting hold of this drug sometimes means frantic calls across county lines. Many countries require a veterinary prescription due to its strong effects and risk of misuse.
Wider access to Denaverine offers clear benefits, but only with strong training and controlled use. Rural clinics need support and clear guidelines to help staff identify cases that truly benefit. Outreach programs tying universities to far-flung farms could mean a smoother learning curve and fewer horror stories from the field. Animal welfare steps forward when science, skill, and availability line up—Denaverine Hydrochloride plays an increasingly valuable role in that progress.
Every drug brings its benefits and its risks. Denaverine Hydrochloride, mostly seen in veterinary medicine for easing muscle spasms, sometimes comes under the spotlight when people ask about its safety. Trust has to be earned with any medication, and first-hand stories from animal owners, as well as vets, mean a lot to me—since my own pet recovered from a tough calving with the help of muscle relaxants like this one.
Muscle relaxants sound helpful, but they tinker with systems that keep things running smoothly. Animals getting Denaverine Hydrochloride often seem unsteady or weaker for an hour or two. It’s not just a sleepy feeling; muscles across the body can get too relaxed, leaving the animal slow to move or oddly clumsy. Vets warn folks to keep animals under close watch until the effects pass. Rapid drops in blood pressure mark one concern; a cow or mare might sway or collapse if pushed too soon or too hard. This isn’t just a theory—farmers and equine owners have talked about these side effects, sometimes blaming themselves until they read the documentation.
Other, more worrying signs include rapid heartbeats, trouble breathing, sweating, or even a kind of confusion. Large doses sometimes bring more drama than relief. Imagine worrying every time your animal shows sudden agitation or breathing changes—I've seen the panic in my neighbor's face when her horse began tremoring and breathing hard after treatment. While the outlook is usually good, reactions like this call for quick action from professionals.
Beyond the one-off reactions, there’s another angle—long-term hormone changes. Some researchers from Germany found that long use can possibly scramble reproductive hormones. In dairy cows, that means less predictable heats or longer times until milk production steadies out. It's not a common risk, but for farmers who rely on tight schedules and healthy cycles, it matters.
Not every animal reacts the same way. Genetics, age, breed, and other health issues all mix up the picture. Doses designed for a big, healthy cow might overwhelm an older or sick one. Friends who manage herds will always talk about the “one cow who can’t handle normal meds.” The same goes for horses—the showy, high-strung ones sometimes get hit hardest.
If you’re using Denaverine Hydrochloride, it pays to go slow and keep a close eye. Always ask about a lower starting dose, especially for weak or older animals. If anything odd shows up—shaking, rapid breathing, collapse—get a call into your vet right away. In my community, sharing these stories has helped new owners stay alert. Folks who write notes on calendars or whiteboards rarely miss a problem. There’s real value in keeping drugs locked up and tracking which animal got what and when.
Researchers still search for safer options, but vigilance and honest reporting help keep animals safe today. Every cough, stumble, or shake deserves attention. Never stop asking questions before and after every treatment.
Denaverine Hydrochloride may not ring the same bell as commonly discussed medications, but for anyone working with animals—especially in veterinary clinics or stables—it shows up at crucial moments. This muscle relaxant finds its role around difficult calvings and lambings, often when things take a complicated turn. So, how professionals use Denaverine can make the difference between relief and ongoing struggle for both animal and handler.
Veterinary teams mostly give Denaverine Hydrochloride by injection. The typical route is intramuscular—directly into the large muscle groups on the animal. For example, cows get shots in the neck or hindquarters. Giving injections in these spots reduces pain for the animal and helps the medicine work as intended. If muscle access is tricky, some vets turn to the slow, steady delivery under the skin, but muscles remain preferred because they absorb the drug faster. Oral forms don’t factor into the picture; Denaverine just does its job best by injection.
Over my years working alongside livestock handlers, I’ve seen plenty of struggle during difficult births. Calves or lambs can get stuck, mothers grow exhausted, and time runs out fast. In those moments, Denaverine’s fast muscle-relaxing action—paired with correct administration—takes the edge off the struggle for both animal and farmers trying to help. The vet draws up the exact dose based on animal weight, follows proper technique, and explains that waiting just a few minutes after injection helps maximize benefits. Poor injection technique or impatience can set back progress, making the next steps riskier for everyone.
As with any drug that affects muscles, Denaverine Hydrochloride isn’t risk-free. If a handler misses the right spot or pushes the needle too deeply, tissue damage can cause lumps, bruising, or—worse—abscesses. Animals may even try to kick, jump, or shy away during administration, which exposes everyone to injury risks. Sometimes, the animal’s system reacts poorly, raising heart rate or blood pressure temporarily. That said, proper training and safety protocols protect against most mishaps.
Not all animals take an injection calmly, so patience and skill matter almost as much as the drug’s properties. I’ve seen experienced vets bring calm to a chaotic barn by working quietly, keeping animals steady, and explaining each step to the handlers. Involving the farmer in holding or reassuring the animal often smooths the entire process. Using sterile equipment for each shot—never reusing needles—reduces complications. Keeping clear notes on doses, times, and responses helps track what worked and what didn’t. It takes diligence, not shortcuts, to make Denaverine truly helpful.
Continuous professional development for veterinary staff makes a huge difference in these critical care moments. Training programs, hands-on demonstrations, and communities of practice give vets confidence to act quickly and safely. Meanwhile, clear communication between vet, handler, and owner helps everyone move in sync—less guessing, less worry. In my own experience, nothing replaces seeing outcomes improve because people took the time to do things right. Smart, skillful administration of medicines like Denaverine saves more than just one animal at a time—it protects relationships, reputations, and peace of mind across the whole barnyard.
Anyone who has worked with livestock or even domestic pets understands that animal pregnancy brings its own set of challenges. There is always a bit of worry every time medication comes into the equation, especially when a trusted vet reaches for a drug like denaverine hydrochloride. This smooth muscle relaxant turns up regularly for easing birth in cattle, mares, and even dogs, with the hope that contractions will become less painful and delivery simpler for the mother.
Decades of use in Europe and elsewhere have made denaverine hydrochloride a familiar name. Vets most often give it just before or during the birthing process to help relax muscles, lower pain, and reduce straining in animals that seem tense or slow to progress. Not every herd manager or breeder feels confident about drugs during pregnancy, though, and for good reason. The safety profile, both for mothers and for newborns, has come up in more than one barn debate.
The veterinary textbooks and regulatory recommendations point to a relatively safe track record. Research points out that denaverine hydrochloride, when used correctly at approved doses, does not cause birth defects or lead to premature labor. In controlled settings across different species, adverse reactions have been rare. The European Medicines Agency and similar organizations have given the green light for its use under veterinary supervision, focusing on well-monitored cases.
There have been scattered reports of minor side effects—like drooling, unease, or short spells of restlessness—but nothing that would put mother or baby at risk if a vet follows the package directions. No scientific studies have shown an increased rate of miscarriage or stillbirth directly linked to this medicine.
Having spent plenty of nights in the calving shed, I have seen denaverine used on nervous heifers that just won’t settle. There is a difference, often clear within thirty minutes: muscles relax, straining slows, and sometimes a healthy calf follows without drama. No medicine works miracles, but alongside skilled care and watchful eyes, denaverine adds a tool to the birthing toolkit that keeps stress low for animals and handlers.
Mares and bitches receive this drug as well, typically after other methods have failed to bring about productive labor. Vets tell me that with proper timing and dosage, the risk of complications drops, and both mother and offspring stand a better chance.
Like any drug, denaverine hydrochloride comes with a catch: it’s not for across-the-board use. Some situations call for extra caution. Animals with liver or kidney troubles, or those on conflicting medications, need double checks. Milk and meat withdrawal times remain set for food animals, and every veterinary professional keeps up with label instructions and updated research.
Good judgment means that not every pregnant animal should get this automatically. Many deliveries happen safely on their own, and unnecessary interventions always carry risks. Responsible use starts with a case-by-case conversation between experienced veterinarians and animal owners, banishing shortcuts and careless dosing.
Trust in denaverine hydrochloride for pregnant animals depends on years of observation, thorough studies, and honest discussion. The path is not about racing to medicate at every sign of trouble, but about pairing knowledge with hands-on experience. Vets and caregivers do best when they lay out all the facts, keep a close eye on the animals, and stay open to new research as it develops. Openness about risks, benefits, and alternatives goes a long way in protecting both animals and the people who look after them.
Anyone who raises cattle, sheep, or horses knows how unpredictable and stressful animal births can get. Vets often turn to Denaverine Hydrochloride to smooth out dystocia and ease the birthing process by relaxing the cervix and uterus. In livestock health, people learn to value drugs that show reliable results without pushing the animal at risk. The right dosage determines if Denaverine guides an animal through labor easily or causes unnecessary complications. A lot rides on getting it right.
Most drug labels from established veterinary pharma companies—those trusted by vets for decades—recommend giving Denaverine Hydrochloride at a dose of 40 mg administered by intramuscular injection. In cows, this often means drawing up the standard 8 ml dosage, since each milliliter contains about 5 mg of Denaverine. For sheep and goats, the dose gets scaled down, usually to about 10 mg intramuscularly. Horse dosages can vary more widely based on the mare’s weight and the veterinarian’s clinical judgment, though the baseline still hovers around 40 mg. Newer research rarely veers from these figures; field experience backs them up year after year.
Too low a dose, and the muscle relaxant barely makes a dent. This frustrates everyone—the animal, the vet, and the farmer cheering from the sidelines. Pump in too much, and the animal becomes weak or struggles to recover quickly, delaying other treatments or risking side effects like hypotension. Safety data published in veterinary pharmacological journals show that at recommended doses, Denaverine rarely causes negative reactions. That gives veterinarians more confidence to use it even in tough cases.
Not every animal is the same—one old dairy cow in my father’s barn handled labor better than five sprightly first-calvers. That’s where a knowledgeable veterinarian comes in. He weighs not only the animal's size but also stress level, hydration, and how far labor has progressed. That's real applied knowledge—the kind gleaned from hours in muddy pens and late-night barn calls, not just from a chart.
Veterinarians also factor in drug interactions. Giving Denaverine alongside other medications, such as oxytocin or calcium borogluconate, can complicate absorption and clinical effects, and this isn’t always clear cut in textbooks. Farm vets will often take a more conservative approach, going with the lower end of dosage guidance for compromised or smaller animals—this isn’t second-guessing science, but adapting recommendations with lived experience.
In some rural areas I’ve worked, access to qualified veterinary care isn’t guaranteed, and farmers self-administer drugs off veterinary supply shelves based only on hearsay or internet forums. This spreads risk. Misdosing can easily turn a manageable calving into a major emergency. Local agricultural extension offices and online continuing education resources have started to fill these knowledge gaps, offering clear, evidence-based dosing tables and guidance for Denaverine Hydrochloride that bridge expertise and local know-how.
If there’s any lesson from the countless barn births I’ve witnessed, it’s that success depends on combining science-backed advice with practical experience. Dosage recommendations for Denaverine Hydrochloride don’t sit in a vacuum—they sit in the middle of busy breeding schedules, worried owners, and unpredictable animals. No one delivers a calf or a lamb by the textbook alone.
| Names | |
| Preferred IUPAC name | 2-\[4-(3-oxo-1-phenylpropyl)piperidin-1-yl]ethyl 2-benzylanilinoacetate hydrochloride |
| Other names |
Denaverinum Denaverine HCl |
| Pronunciation | /dɛˈneɪvəˌriːn haɪˌdrɒkləˈraɪd/ |
| Identifiers | |
| CAS Number | 56353-18-7 |
| Beilstein Reference | 3382203 |
| ChEBI | CHEBI:3168 |
| ChEMBL | CHEMBL2104603 |
| ChemSpider | 80558 |
| DrugBank | DB13520 |
| ECHA InfoCard | 03e648bc-98e6-4106-8eaf-96c6918976d5 |
| EC Number | 251-656-2 |
| Gmelin Reference | 77496 |
| KEGG | D01712 |
| MeSH | D03INB8W2L |
| PubChem CID | 124219 |
| RTECS number | DH6650000 |
| UNII | Y4238411T5 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C19H25NO2·HCl |
| Molar mass | 370.94 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.22 g/cm³ |
| Solubility in water | Soluble in water |
| log P | 1.77 |
| Acidity (pKa) | 9.4 |
| Basicity (pKb) | 5.89 |
| Magnetic susceptibility (χ) | -47.5e-6 cm³/mol |
| Refractive index (nD) | 1.571 |
| Dipole moment | 3.34 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 337.6 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | QA92AX92 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS05, GHS07, Danger, H302, H315, H319, H335 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P260, P264, P270, P271, P273, P301+P312, P304+P340, P305+P351+P338, P312, P330, P403+P233, P405, P501 |
| Flash point | > Flash point: 208.7 °C |
| Lethal dose or concentration | LD₅₀ (rat, oral): 400 mg/kg |
| LD50 (median dose) | LD50 (median dose): 209 mg/kg (intravenous, mouse) |
| PEL (Permissible) | Not established |
| REL (Recommended) | 5 mg/kg |
| Related compounds | |
| Related compounds |
Papaverine Benzydamine Drotaverine Cinepazide Etofylline clofibrate |